[Form 4] HeartBeam, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Mark E. Strome, a director of HeartBeam, Inc. (BEAT), reported transactions showing an indirect holding of 3,150,000 shares held by affiliated entities and a direct sale of 57,146 shares on 07/01/2025. The filing states Mr. Strome has authority to vote and dispose of the shares held by Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust, and Strome Dynasty, LLC, and disclaims beneficial ownership except for his pecuniary interest.

The report also discloses equity awards: 60,483 restricted stock units granted on 07/11/2025 that vest on the earlier of 07/11/2026 or the 2026 annual meeting (subject to continued service as an Outside Director), and options covering 36,364 shares with an exercise price of $1.65 (granted 09/30/2025) and a vesting schedule tied to the July 1, 2025 commencement date. The filing is signed by Mr. Strome on 10/02/2025.

Positive

• 3,150,000 shares held indirectly by affiliated entities indicating significant stake
• 60,483 RSUs granted on 07/11/2025 that vest by 07/11/2026, aligning director pay with shareholders
• 36,364 options issued with an exercise price of $1.65, promoting long-term retention

Negative

• 57,146 shares were disposed of (sold) on 07/01/2025

Insights

Corporate Governance Expert

Large indirect stake plus director awards indicate continued alignment with the company.

What it means: The report shows an indirect position of 3,150,000 shares controlled through affiliated vehicles while Mr. Strome also sold 57,146 shares on 07/01/2025. The disclosure that he has voting and dispositive authority over the entities is factual and typical for founder- or investor-affiliated holdings.

Why it matters: A sizeable indirect stake of 3.15M shares signals material ownership that can influence governance votes. The grant of 60,483 RSUs (vesting by 07/11/2026) and 36,364 options at $1.65 aligns the director’s compensation with equity performance and ties long-term retention to continued board service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

STROME MARK E

(Last) (First) (Middle)

2118 WALSH AVENUE, SUITE 210

(Street)

SANTA CLARA CA 95050

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								3,150,000	I	See Footnote(1)
Common Stock								57,146	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Award	$0							(2)	(3)	Common Stock	60,483		60,483	D
Common Stock (right to buy)	$1.65							(4)	09/30/2035	Common Stock	36,364		36,364	D

Explanation of Responses:

1. The reported securities are held directly by Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust and Strome Dynasty, LLC. Mr. Strome has the authority to vote and dispose of the reported securities held by each of these entities. Mr. Strome disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Strome is a beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

2. These securities are restricted stock units (RSUs) granted on July 11, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

3. RSUs do not expire, they either vest or are canceled prior to vesting date

4. Granted options on September 30, 2025, one half of the total number of Shares subject to the Special Option shall vest on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remaining Shares shall vest on the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Remarks:

	/s/ Mark E. Strome	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HeartBeam (BEAT) director Mark E. Strome report on Form 4?

Mr. Strome reported an indirect holding of 3,150,000 shares, a direct sale of 57,146 shares on 07/01/2025, 60,483 RSUs granted on 07/11/2025, and 36,364 options at $1.65.

Who holds the 3,150,000 shares reported by Mark E. Strome?

The shares are held directly by Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust, and Strome Dynasty, LLC, where Mr. Strome has voting and dispositive authority.

When do the RSUs reported by Mark E. Strome vest?

The 60,483 RSUs vest 100% on the earlier of 07/11/2026 or the Issuer's 2026 annual meeting, subject to continued service as an Outside Director.

What are the terms of the options granted to Mark E. Strome?

The Form 4 discloses options for 36,364 shares with an exercise price of $1.65, granted on 09/30/2025, with a vesting schedule tied to the July 1, 2025 commencement date.

Did Mark E. Strome sign the Form 4 and when?

Yes. The Form 4 is signed by Mark E. Strome on 10/02/2025.